PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.66%
Net income growth under 50% of AVGO's 33.33%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
6.25%
D&A growth of 6.25% while AVGO is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-429.63%
Negative yoy deferred tax while AVGO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
19.31%
Less working capital growth vs. AVGO's 115.15%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
917.24%
AR growth well above AVGO's 77.78%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-37.88%
Negative yoy inventory while AVGO is 33.33%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Both reduce yoy usage, with AVGO at -233.33%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-633.33%
Negative yoy while AVGO is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-6.68%
Negative yoy CFO while AVGO is 58.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.99%
Some CapEx rise while AVGO is negative at -36.36%. John Neff would see competitor possibly building capacity while we hold back expansions.
-137.29%
Negative yoy acquisition while AVGO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-16.25%
Negative yoy purchasing while AVGO stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.63%
Liquidation growth of 12.63% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
17.22%
We have mild expansions while AVGO is negative at -3.45%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
600.00%
Stock issuance far above AVGO's 100.00%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.